Overview

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial

Status:
Completed
Trial end date:
2014-07-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if SU011248 works and if it is safe in patients with advanced transitional cell carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
AHS Cancer Control Alberta
Alberta Health Services
Collaborator:
Pfizer
Treatments:
Sunitinib